Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease
Marietta Iacucci(University Hospitals Birmingham NHS Foundation Trust), Subrata Ghosh, Silvio Danese(IRCCS Ospedale San Raffaele), Irene Zammarchi(APC Microbiome Institute), Rocío del Amor(Universitat Politècnica de València), Giovanni Santacroce(Università Cattolica del Sacro Cuore), Pablo Meseguer(Artificial Intelligence Research Institute), Antonio Di Sabatino(University of Pavia), Bisi Bode Kolawole(London South Bank University), Yuichi Mori(Showa University Northern Yokohama Hospital), Ujwala Chaudhari(London South Bank University), Enrico Grisan(University of Padua), Yasuharu Maeda(University College Cork), Valery Naranjo(Universitat Politècnica de València)
Cited by 63
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2019|1.2k
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
|Journal of Crohn s and Colitis|2021|1.1k